Sristi Bio-Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.81 Cr
- Company Age 15 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.40 M
- Revenue Growth -6.92%
- Profit Growth -353.69%
- Ebitda 21.89%
- Net Worth -0.75%
- Total Assets 13.73%
About Sristi Bio-Sciences
Sristi Bio-Sciences Private Limited (SBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 February 2010 and has a history of 15 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.81 Cr.
The company currently has active open charges totaling ₹1.40 M.
Jayaraman Packirisamy and Kalakata Reddy serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24297TG2010PTC067012
- Company No.
067012
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Sristi Bio-Sciences Private Limited offer?
Sristi Bio-Sciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Ayurvedic & Herbal Extracts, Spices Extracts.
Who are the key members and board of directors at Sristi Bio-Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayaraman Packirisamy  | Director | 15-Feb-2010 | Current |
| Kalakata Reddy | Director | 15-Feb-2010 | Current |
Financial Performance of Sristi Bio-Sciences.
Sristi Bio-Sciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 6.92% decrease. The company also saw a substantial fall in profitability, with a 353.69% decrease in profit. The company's net worth dipped by a decrease of 0.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sristi Bio-Sciences?
In 2023, Sristi Bio-Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Organova Bio-Agriculture Private LimitedJayaraman Packirisamy is a mutual person
Electrospunra Nanofibers (India) Private LimitedJayaraman Packirisamy and Kalakata Reddy are mutual person
- Insight Bioventures India Private Limited
Jayaraman Packirisamy and Kalakata Reddy are mutual person
- Morus-Gastur Cell Therapeutics Private Limited
Jayaraman Packirisamy and Kalakata Reddy are mutual person
- Qbd Analytics Services Private Limited
Jayaraman Packirisamy and Kalakata Reddy are mutual person
- Sk Bio Manufacturing Private Limited
Jayaraman Packirisamy is a mutual person
Charges (Loans)
₹0.14 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2021 | Hdfc Bank Limited | ₹1.40 M | Open |
How Many Employees Work at Sristi Bio-Sciences?
Unlock and access historical data on people associated with Sristi Bio-Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sristi Bio-Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sristi Bio-Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
